We invite you to join us for the 1st Annual Best of Lung Cancer conference. This innovative and state of the art program will feature some of the world's leading lung cancer experts to present the latest research and strategies for the care of lung cancers — incorporating data from the major oncologic annual meetings.
Register free today to join the program virtually as our speakers present from Palm Beach, Florida.
Accreditation Information | TBD
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of TBD ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of TBD AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of TBD knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to TBD Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
Describe current and evolving management strategies for patients with localized and locally advanced lung cancer.
Identify best practices in biomarker testing and the utilization of biomarkers to drive treatment decisions for patients with lung cancer.
Explain the application of targeted therapy and immunotherapy in the treatment of NSCLC.
Outline the clinical trial data on the use of molecular drivers in the management of patients with advanced lung cancers.
Summarize current and emerging strategies in the management of patients with advanced lung cancer without driver mutations.
What to Expect
Free registration for all healthcare providers
Expert video sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Virtual networking with peers, colleagues, and medical professionals
Virtual access to the latest industry information and resources